PKM and cancer: O-glycosylation at sites T405 and S406 in PKM2 also causes the transition of PKM2 from tetrameric to dimeric form, which results in PKM2 nuclear translocation and inhibits its pyruvate kinase activity, effectively promoting the development of cancer [168].